These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 476142)

  • 1. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents.
    Ponka P; Borová J; Neuwirt J; Fuchs O; Necas E
    Biochim Biophys Acta; 1979 Aug; 586(2):278-97. PubMed ID: 476142
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes.
    Ponka P; Richardson D; Baker E; Schulman HM; Edward JT
    Biochim Biophys Acta; 1988 Oct; 967(1):122-9. PubMed ID: 3167093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent.
    Ponka P; Borová J; Neuwirt J; Fuchs O
    FEBS Lett; 1979 Jan; 97(2):317-21. PubMed ID: 761636
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone.
    Ponka P; Grady RW; Wilczynska A; Schulman HM
    Biochim Biophys Acta; 1984 Dec; 802(3):477-89. PubMed ID: 6509088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilise iron from reticulocytes in vitro.
    Ponka P; Richardson DR; Edward JT; Chubb FL
    Can J Physiol Pharmacol; 1994 Jun; 72(6):659-66. PubMed ID: 7954097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the mechanism of action of pyridoxal isonicotinoyl hydrazone at the cellular level using reticulocytes loaded with non-heme 59Fe.
    Huang AR; Ponka P
    Biochim Biophys Acta; 1983 Jun; 757(3):306-15. PubMed ID: 6849979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes.
    Ponka P; Schulman HM; Wilczynska A
    Biochim Biophys Acta; 1982 Oct; 718(2):151-6. PubMed ID: 7138909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron.
    Richardson DR; Mouralian C; Ponka P; Becker E
    Biochim Biophys Acta; 2001 May; 1536(2-3):133-40. PubMed ID: 11406348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.
    Buss JL; Neuzil J; Gellert N; Weber C; Ponka P
    Biochem Pharmacol; 2003 Jan; 65(2):161-72. PubMed ID: 12504792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S
    J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
    Buss JL; Arduini E; Ponka P
    Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilize iron from reticulocytes in vitro: reappraisal of reported partition coefficients.
    Edward JT; Chubb FL; Sangster J
    Can J Physiol Pharmacol; 1997 Dec; 75(12):1362-8. PubMed ID: 9534947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelator-mediated iron efflux from reticulocytes.
    Morgan EH
    Biochim Biophys Acta; 1983 Aug; 733(1):39-50. PubMed ID: 6882755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.
    Brittenham GM
    Ann N Y Acad Sci; 1990; 612():315-26. PubMed ID: 2291560
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs.
    Buss JL; Ponka P
    Biochim Biophys Acta; 2003 Jan; 1619(2):177-86. PubMed ID: 12527114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.
    Richardson D; Baker E; Ponka P; Wilairat P; Vitolo ML; Webb J
    Birth Defects Orig Artic Ser; 1988; 23(5B):81-8. PubMed ID: 3390577
    [No Abstract]   [Full Text] [Related]  

  • 18. An in vivo evaluation of iron-chelating drugs derived from pyridoxal and its analogs.
    Johnson DK; Pippard MJ; Murphy TB; Rose NJ
    J Pharmacol Exp Ther; 1982 May; 221(2):399-403. PubMed ID: 7077535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E; Vitolo ML; Webb J
    Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    Kovaríková P; Mrkvicková Z; Klimes J
    J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.